AI Summary & Key Takeaways
AI InsightTherefore, healthcare practitioners and providers should assess women’s risk factors for FSD, arrange for extra follow-upand assist with early diagnosis and treatment to improve women’s sexual life.
📌 3 Key Takeaways
Abstract
Objective: Female sexual dysfunction is a common condition that negatively impacts the psychological health and quality of life of the affectedindividuals. Therefore, this study aims to assess sexual function changes in women using hormonal and non-hormonal contraceptives.Methods: We assessed 380 women who visited three Family Health Centers in Manisa, Turkey. Female Sexual Function Index (FSFI) andBeck Depression Inventory (BDI) questionnaires were used to get data. Regression and correlation analyses were applied to determine therelationship and level of sexual function of participants.Results: According to FSFI cut-off score ≤26.55, the prevalence of female sexual dysfunction (FSD) was determined in 35.4% and 48.0% of sexualfunction changes and FSFI score was found 26.5±4.3 and 27.1±4.1 in women using non-hormonal and hormonal contraceptives. In regressionanalysis, women having higher education, satisfied with their sexual life, and women stating that their husband satisfied with non-hormonalcontraceptive usage had high score in FSFI. Of those women, 6.6% scored ≥17 on the BDI.Conclusion: The use of hormonal and non-hormonal contraceptives is important for the improvement sexual quality of women planningappropriate initiatives. Therefore, healthcare practitioners and providers should assess women’s risk factors for FSD, arrange for extra follow-upand assist with early diagnosis and treatment to improve women’s sexual life.